
21/08/2025
Fighting Colorectal Cancer Starts with Early Detection—Our FOB Rapid Test Leads the Way
Colorectal cancer (CRC) – now the world’s #2 cancer killer (904K deaths in 2022). Here’s the critical truth: 90% of CRC patients survive 5+ years if caught at Stage I, but that number plummets to just under 20% at Stage IV. The gap? Too many cases are detected too late.
That’s where our Accu-Tell® FOB Rapid Test comes in.
F***l Occult Blood (FOB)—hidden blood in stool—is one of the earliest, most reliable signs of CRC or pre-cancerous polyps. Unlike invasive procedures, our FOB test delivers fast, accurate results to identify risk *before* symptoms appear—when intervention is most effective.
Our Accu-Tell® FOB Test: Engineered for Impact
Designed for healthcare providers, clinics, and population-wide screening programs, our test solves the biggest barriers to early CRC detection:
✅ 99.5% clinical agreement (200-sample validation)
✅ Ultra-sensitive (40ng/mL detection), unaffected by diet or animal hemoglobin
✅ Results in 5 mins – no complex equipment needed
✅ Cost-effective for mass screening programs
🌐 Global Impact, Local Action
From urban clinics to remote communities, our FOB solutions scale CRC defense
🔗 Learn how AccuBioTech partners with health systems: www.accubiotech.com
➡️ Request samples or bulk quotes:sales@accubiotech.com